In persistent pulmonary hypertension of the newborn (PPHN) a sustained rise in pulmonary vascular resistance diverts blood from the lungs, causing a ventilation-perfusion mismatch. Pulmonary vasodilatation cannot be relieved without correction of the resultant hypoxia and acidosis and conventional treatments include mechanical ventilation (to produce hyperoxia and hypocapnia), administration of bicarbonate and inotropic agents, intravascular volume support, and normalization of serum electrolytes and glucose. If these fail, others include magnesium sulphate, prostacyclin, inhaled nitric oxide (iNO), dipyridamole, high-frequency ventilation and extracorporeal membrane oxygenation (ECMO).
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Use of dipyridamole has been described only in conjunction with iNO. We have used it as sole therapy.
CASE HISTORY
A male baby, born at term, was admitted with PPHN on day 1 of life for venovenous ECMO after failure of conventional treatment. He was severely asphyxiated at birth, with Apgar scores of 1 and 3 at 1 and 5 minutes and initial arterial blood pH 6.9, PaO 2 3.23 kPa and base de®cit 718.2. He was treated with mechanical ventilation (FiO 2 1.0, pressure 40/5 and respiratory rate 60/min) and intermittent hand-bagging to maintain oxygen saturations 470%, intravenous magnesium sulphate, iNO, dopamine and arti®cial surfactant. Before transfer to our hospital for ECMO his oxygen index was 43 with arterial blood pH 7.27, PaO 2 5.2 kPa, PaCO 2 3.56 kPa and base de®cit 712.
Echocardiography before ECMO revealed normal cardiac anatomy but a large unrestrictive patent ductus arteriosus with¯ow from right to left indicating suprasystemic pulmonary artery pressures. During the ®rst week of ECMO, pulmonary artery pressures remained suprasystemic. On day 7 he was treated with iNO (up to 80 ppm) and prostacyclin infusion. These had no effect on pulmonary artery pressure and were stopped after 24 hours; dipyridamole was then started at a dose of 4 mg/kg intravenously twice daily.
Echocardiography the next day showed a fall in pulmonary artery pressure to systemic levels. In the ensuing days the baby was weaned off life support and ECMO was discontinued on day 14. Echocardiography after ECMO showed a small restrictive patent ductus with mainly left to right¯ow and pulmonary artery pressures 20 mmHg lower than systemic. After ECMO he remained stable on low mechanical ventilatory support. Dipyridamole was continued for 4 days and then slowly withdrawn over a further 4 days during which his pulmonary artery pressures remained normal. However, repeat echocardiography 4 days after discontinuation of dipyridamole showed pulmonary artery pressures again suprasystemic. These ®ndings contradicted his clinical picture since he remained well with progressively declining ventilatory requirements. Dipyridamole was restarted and echocardiography 2 days later showed bidirectional ductal¯ow, although predominantly left to right, indicating equal pulmonary artery and systemic pressures. Dipyridamole was continued for a further 10 days during which he was successfully extubated. Echocardiography at one month of age, when all treatment had been stopped, showed subsystemic pulmonary artery pressures. He was discharged well, back to the referring hospital.
COMMENT
Dipyridamole, which reduces pulmonary artery pressure and pulmonary vascular resistance in many diseases associated with pulmonary hypertension, is thought to act by inhibiting cyclic guanine monophosphate (cGMP) speci®c phosphodiesterase. Endogenous and iNO-induced pulmonary vasodilatation is mediated through increased cGMP production in vascular smooth muscle 1 . Dipyridamole inhibition of phosphodiesterase inactivation of cGMP may increase both the potency and the duration of vasodilatation by increasing the concentration of cGMP in smooth muscle cells 2 . Dipyridamole also inhibits platelet adhesion and aggregation probably through increased intraplatelet cyclic adenosine monophosphate. Mild bleeding, if dipyridamole is used in conjunction with other anticoagulants, is a potential side effect.
Experiments in animals and case reports in man indicate that dipyridamole can reduce pulmonary vascular resistance in PPHN either by augmenting the response to iNO or by reducing rebound hypertension on its withdrawal 3±5 .
Similar effects were observed in pulmonary hypertension following surgery for congenital cardiac disorders and in childhood primary pulmonary hypertension 6 . Dipyridamole is not widely used in pulmonary hypertension but our success with sole therapy, coupled with previous reports, suggests that it merits further investigation, at a time when the ef®cacy of iNO is in doubt. The most common source of graft prosthesis infection after vascular reconstructive surgery is the skin¯ora, but infection can also arise from an intra-abdominal in¯ammatory event.
CASE HISTORIES

Case 1
A man aged 77 had his 9 cm leaking abdominal aortic aneurysm repaired with an aorto-iliac graft. 4 years later he was referred with a few days' history of central abdominal pain, anaemia and melaena. On examination he had a tender mass in the right iliac fossa and a bleeding duodenal ulcer was found on endoscopy. Leukocyte count was 26610 9 /L and blood cultures grew Klebsiella and Escherichia coli; he was started on intravenous cefotaxime. After he passed a further 400 mL fresh blood per rectum, he was taken to theatre. At laparotomy pus was found seeping from the proximal graft suture line and below was a secondary aorto-duodenal ®stula. The appendix was closely adherent to the underlying graft, which was bile-stained. The right limb was thrombosed within an envelope of pus. Proximally, a loop of ileum also had a 1 cm diameter paraprosthetic contact with the right limb ( Figure 1) . The ®stulae were closed and appendectomy was performed. Histological examination revealed granulation tissue on the external surface of the appendix, presumably associated with the paraprosthetic ®stula, and chronic active appendicitis. A right axillo-bifemoral bypass was performed before removal of the infected prosthesis. The bed of the infected graft was irrigated with aqueous povidone iodine. The patient was readmitted two months later with an abscess in his right thigh which drained 600 mL of pus containing E. coli, and
